Delivery Order SPE2DR25D2106-SPE2DR26F1FPZ
- Not listed
- The Defense Logistics Agency awarded a $3,819.87 delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,812.04 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets in a 90-count quantity. The contract, which became effective on October 27, 2025, with an ultimate completion date of October 28, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Valsartan-HCTZ 320-12.5 mg tablets in a 90-count quantity, with a ceiling value of $2,955.68. This firm fixed-price delivery order, with an ultimate completion date of November 6, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valsartan-HCTZ 80-12.5 mg tablets (90-count) under a firm fixed-price contract valued at $1,049.19. The award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025, and no set-aside designation was applied. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $36,196.14 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on August 12, 2025, with completion targeted for August 13, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procedures and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,397.13 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-12.5 mg tablets (90-count supply) on September 24, 2025, with completion scheduled for September 25, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valsartan-HCT 160-25 mg tablets (90-count) with a ceiling value of $1,531.19. The award was made on November 4, 2025, with an ultimate completion date of November 5, 2025, under a firm fixed-price delivery order contract. This non-competitive award represents a single delivery against AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets in a quantity of 90 units. This firm fixed-price delivery order, valued at $2,862.12, represents a non-competitive set-aside award and is scheduled for completion by October 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Valsartan-HCTZ 80-12.5 mg tablets (90-count) with a ceiling value of $27,543.66. This firm fixed-price contract represents a non-competitive set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DR25D2106Indefinite Delivery Contract
- SPE2DR25D2106-SPE2DR26F1FPZDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) under a firm fixed-price contract with a ceiling value of $2,530.91. The award was issued on November 7, 2025, with an ultimate completion date of November 10, 2025. This non-competitive delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a routine pharmaceutical procurement within the agency's medical supply operations. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability across multiple therapeutic domains and consistent performance in federal procurement has established it as a critical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/7/25 |